![Jeff Stephens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeff Stephens
Founder at Infusion 51A LP
Profile
Jeff Stephens is the founder of Infusion 51A LP, where he holds the title of Managing Partner starting in 2015.
He is also the founder of Camp Athlete, Inc. Jeff's current job is as the Chief Executive Officer at International Infusion LP.
He is also the Managing Partner at International Infusion Advisors LLC, a position he has held since 2009.
Additionally, Jeff is the Chief Executive Officer at International Infusion, Inc. Jeff's former positions include Director at Theralink Technologies, Inc. (Colorado) and Director at Vivacitas Oncology, Inc. Jeff received his undergraduate degree from the University of Southern Indiana.
Jeff Stephens active positions
Companies | Position | Start |
---|---|---|
International Infusion Advisors LLC
![]() International Infusion Advisors LLC Investment ManagersFinance International Infusion Advisors LLC provides investment advisory services. The private company is based in Chicago. | Corporate Officer/Principal | 2008-12-31 |
Camp Athlete, Inc.
![]() Camp Athlete, Inc. Movies/EntertainmentConsumer Services Camp Athlete, Inc. provides sports related services. The private company is based in Chicago. The American company was founded by Jeff Stephens. | Founder | - |
Infusion 51A LP | Founder | 2014-12-31 |
International Infusion, Inc. | Chief Executive Officer | 2008-12-31 |
International Infusion LP | Chief Executive Officer | - |
Former positions of Jeff Stephens
Companies | Position | End |
---|---|---|
Vivacitas Oncology, Inc.
![]() Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Vivacitas Oncology, Inc. is a private clinical stage biopharmaceutical company founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a, LP. The company is based in Walnut Creek, CA. Vivacitas Oncology is focused on combating cancers that have proven to be resistant to current treatment modalities. The company aims to improve upon well-known chemotherapies with demonstrated effect, but which also possess challenges with potency, toxicity, stability, and other issues limiting their use. The CEO is Mark J. Suseck. | Director/Board Member | - |
AVANT DIAGNOSTICS INC | Director/Board Member | - |
Training of Jeff Stephens
University of Southern Indiana | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
Infusion 51A LP | Miscellaneous |
International Infusion Advisors LLC
![]() International Infusion Advisors LLC Investment ManagersFinance International Infusion Advisors LLC provides investment advisory services. The private company is based in Chicago. | Finance |
Camp Athlete, Inc.
![]() Camp Athlete, Inc. Movies/EntertainmentConsumer Services Camp Athlete, Inc. provides sports related services. The private company is based in Chicago. The American company was founded by Jeff Stephens. | Consumer Services |
International Infusion, Inc. | |
International Infusion LP | |
Vivacitas Oncology, Inc.
![]() Vivacitas Oncology, Inc. Medical/Nursing ServicesHealth Services Vivacitas Oncology, Inc. is a private clinical stage biopharmaceutical company founded in 2015 by Dr. Joseph Rubinfeld and Infusion 51a, LP. The company is based in Walnut Creek, CA. Vivacitas Oncology is focused on combating cancers that have proven to be resistant to current treatment modalities. The company aims to improve upon well-known chemotherapies with demonstrated effect, but which also possess challenges with potency, toxicity, stability, and other issues limiting their use. The CEO is Mark J. Suseck. | Health Services |
Theralink Technologies, Inc. (Colorado)
![]() Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Stock Market
- Insiders
- Jeff Stephens